Approximately 52,171 units of Clobetasol Propionate Foam (0.05%), including both standard and emulsion formulations, have been recalled. This prescription topical medication, manufactured by Glenmark Pharmaceuticals, is being recalled because the delivery system is defective, causing the product to come out as a liquid or fail to foam entirely. Consumers should contact their healthcare provider or pharmacist regarding this recall and for guidance on alternative treatments.
The defective delivery system prevents the medication from dispensing as the required foam, resulting in a liquid consistency that may affect how the drug is applied to the skin or the dosage administered. While the risk level is low, a failing delivery system can prevent the patient from receiving the medication in its intended form.
Healthcare provider consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.